SMAD4 and colorectal carcinoma: We have recently reported that loss of SMAD4-promoted CCL15 expression from CRC cells to recruit CCR1+ myeloid cells through the CCL15-CCR1 axis, and that CCL15 expression in primary and metastatic CRCs was a predictor of CRC patients’ prognosis [73,74,75].